Posted by Michael Wonder on 03 Jun 2021
FDA grants priority review for new drug application for Oleogel-S10 for the treatment of epidermolysis bullosa
3 June 2021 - PDUFA date of 30 November 2021 set for Oleogel-S10.
Amryt today announces that the U.S. FDA has granted priority review for Amryt’s bew drug application for Oleogel-S10 for the treatment of epidermolysis bullosa.
Read Amryt Pharma press release
